Cue Health, best known for its at-home COVID-19 molecular test, will launch its own virtual health platform, pushing the company outside of the diagnostics space, MobiHealthNews reports
The direct-to-consumer platform, available next week, will include on-demand access to doctors, guided COVID-19 testing, prescriptions and physician-ordered lab tests. The virtual care offerings are part of a membership program, where customers can pay a monthly fee for a number of tests per year, plus discounts on a Cue Reader and additional tests.
Once a more niche method of healthcare delivery, telehealth and virtual-care use exploded during the pandemic as patients and providers avoided unnecessary in-person care. Though telehealth utilization had been declining in June and July, FAIR Health’s Monthly Telehealth Regional Tracker found utilization grew nationally in August, particularly in the South as the delta variant spread in the region. Read more.
